State lawmakers have filed psychedelics-related bills, many aimed at exploring access to and potential uses for substances ...

FDA's rejection of MDMA therapy for PTSD doesn't dampen hopes for other psychedelic treatments. Read more here.

More than four hours before police arrived, Denise Lozano, a longtime employee of Vista-based natural soap maker Dr.

The Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the potential to transform treatments for neuropsychiatric disorders. Delivered in ...

Cybin Inc. (Cboe Canada CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative ...

It’s important to note that researchers are likely at least 10 to 30 years away from creating mirror bacteria. On the timescale of a fast-moving field like synthetic biology, a decade is a very long ...